Effect of acute pentoxifylline treatment in an experimental model of colitis

Alimentary Pharmacology and Therapeutics

Volumn 11, Issue 3, 1997, Pages 575-580

  Peterson, T C ^a   Davey, K ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; PENTOXIFYLLINE; TRINITROBENZENESULFONIC ACID;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; COLON; CONTROLLED STUDY; DRUG ADMINISTRATION; DRUG EFFECT; HISTOPATHOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030855298     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1997.00188.x     Document Type: Article

References (19)

1. Morris GP, Beck PL, Herridge MS, et al. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989; 96: 795-803.
2. Ward M. The pathogenesis of Crohn's disease. Lancet 1977; ii: 903-5.
3. Shorter RG, Huizenga KA, Spencer RJ. A working hypothesis Cor the aetiology and pathogenesis of nonspecific inflammatory bowel disease. Am J Dig Dis 1972; 17: 1024-32.
4. Ward A, Clissold SP. Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy. Drugs 1987; 34: 50-97.
5. Peterson TC. Pentoxifylline prevents fibrosis in an animal model and inhibits platelet derived growth factor driven proliferation of fibroblasts. Hepatology 1993; 17(3): 486-93.
6. Graham MF, Diegelmann RF, Elson C, et al. Collagen content and types of intestinal strictures of Crohn's disease. Gastroenterology 1988; 94: 257-65.
7. Stalmach A, Schuppan D, Riese H, Matthes H, Riecken E. Increased collagen type III synthesis by fibroblasts isolated from strictures of patients with Crohn's diseuse. Gastroenterology 1992; 102: 61 920-9.
8. Santucci L, Fiorucci S, Giansanti M, et al. Pentoxifylline prevents indomethacin induced acute gastric mucosal damage in rats: role of tumour necrosis factor alpha. Gut 1994; 35: 909-15.
9. Lopez-de Leon A, Rojkind M. A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections. J Histochem Cytochem 1985; 33(8): 737-43.
10. Zar JH. Biostatistical Analysis. Englewood Cliffs, NJ: Prentice-Hall, 1974.
11. Harada K, Toyonage A, Mitsuyama K, Sasaki E, Tanikawa K. Role of cytokine-induced neutrophil chemoattractant, a member of the interleukin-8 family, in rat experimental colitis. Digestion 1994; 55: 179-84.
12. Neilly P, Gardiner K, Kark S, et al. Endotoxemia and cytokine production in experimental colitis. Br J Surg 1995; 82: 1479-82.
13. Santucci L, Fiorucci S, Di-Matteo F, Morelli A. Role of tumor necrosis factor alpha release and leukocyte margination in indomethacin induced gastric injury in rats. Gastroenterology 1995; 108: 393-401.
14. Neurath M, Pettersson S, Mayer-Zum-Buschenfelde K, Strober W. Local administration of antisense phosphorothioate oligonucleotides to the p-65 sub unit of NF-kappaB abrogates established experimental colitis in mice. Nature Med 1996; 2: 998-1004.
15. Freeman HJ. Giant cell vasculitis and microscopic (collagenous-lymphocytic) colitis. Can J Gastroenterol 1995; 7: 8616-20.
16. Peterson TC, Tanton RT. Effect of pentoxifylline in collagenous colitis. Can J Gastroenterol 1996; 10(Suppl. A): 39A.
17. Isbrucker RA, Peterson TC. Effect of PDGF, pentoxifylline and metabolite-1 on collagen production in porcine hepatic stellate cells. Hepatology 1995; 22(4): A696(Abstract).
18. Biswas DK, Dezube B, Ahlers C, Pardee A. Pentoxifylline inhibits HIV-ILTR-driven gene expression by blocking NF-kappaB action. J Acquir Immune Defic Syndr 1993; 6: 778-86.
19. Peterson TC, Tanton, RT. Effect of pentoxifylline in collagenous colitis: A new therapy? Gastroenterology 1996; 110(4): A990(Abstract).